Sergey Gurevich, MD

Assistant Professor of Medicine, Cardiovascular Division

Sergey Gurevich

Contact Info

Mailing Address:
420 Delaware Street, SE
MMC 508
Minneapolis, MN 55455

Administrative Assistant Name
Roberta Beach

Administrative Email

Assistant Professor of Medicine, Cardiovascular Division

Interventionalist, Cardiologist

Medical School, Medical College of Wisconsin, Milwaukee, WI

Residency, Weill Cornell Medical Center, New York, NY

Fellowship, University of Minnesota Medical Center, Minneapolis, MN


Dr. Sergey Gurevich is an interventional cardiologist with University of Minnesota Health. Dr. Gurevich competed his medical school at the Medical College of Wisconsin and his residency at New York Presbyterian-Weill Cornell Medical College. He joined the University of Minnesota Cardiovascular general fellowship in July of 2015 and subsequently completed his interventional training in 2018. Following his fellowship, he was asked to join the cardiovascular section at the University of Minnesota Medical School where his clinical focus has been primarily interventional coronary procedures including complex coronary intervention with mechanical circulatory support and chronic total occlusions.

His research interests have focused on improving transcatheter therapies for structural heart disease including transcatheter aortic valve replacement and transcatheter mitral therapies. His translational research has been focused on implementation of emerging technologies into clinical practice. His work has been featured at several national and international conferences with a number of publications in peer-reviewed journals.


  • Transcatheter therapies for structural heart disease

Professional Associations

  • Society for Cardiovascular Angiography and Interventions (07/2015-present)
  • American College of Cardiology (07/2015-present)
  • American College of Physicians (09/2008–Present)
  • American Medical Association (07/2011-present)


Research Summary/Interests

Dr. Gurevich's research focus is transcatheter therapies for structural heart disease


  • Gurevich S, Oestreich B, Kelly RF, Mbai M, Bertog S, Ringsred K, Lawton A, Thooft B, Wagner J, Garcia S. Outcomes of transcatheter aortic valve replacement using a minimalist approach. Cardiovasc Revasc Med. 2018 Mar;19(2):192-195. doi: 10.1016/j.carrev.2017.08.002. Epub 2017 Aug 12. PMID: 28923694.
  • Gurevich S, Oestreich B, Kelly RF, Mbai M, Bertog S, Yannopoulos D, Garcia S. Routine use of anticoagulation after transcatheter aortic valve replacement: Initial safety outcomes from a single-center experience. Cardiovasc Revasc Med. 2018 Jul-Aug;19(5 Pt B):621-625. doi: 10.1016/j.carrev.2017.12.001. Epub 2017 Dec 6. PMID: 29276174.
  • Gurevich S, Reiff C, Bertog S, Mbai M, Kelly RF, Soule M, Yannopoulos D, Garcia S. Transcatheter Aortic Valve Replacement Improves Health Status in Elderly Veterans. J Invasive Cardiol. 2018 Jun;30(6):207-211. PMID: 29799425.
  • Reiff C, Zhingre Sanchez JD, Mattison LM, Iaizzo PA, Garcia S, Raveendran G, Gurevich S. 3-Dimensional printing to predict paravalvular regurgitation after transcatheter aortic valve replacement. Catheter Cardiovasc Interv. 2020 Dec;96(7):E703-E710. doi: 10.1002/ccd.28783. Epub 2020 Feb 20. PMID: 32077222.
  • Gurevich S, Prins KW. The evolving role of interventional cardiology in the treatment of pulmonary hypertension. Catheter Cardiovasc Interv. 2021 Mar;97(4):E446-E453. doi: 10.1002/ccd.29146. Epub 2020 Aug 1. PMID: 32738190; PMCID: PMC7854792.


Clinical Interests

Cardiac CT, Coronary artery disease and intervention, Coronary artery disease (stable and unstable angina, myocardial, infarction), Coronary physiology, Hemodynamics, Interventional cardiology, Invasive hemodynamics, Mechanical circulatory support, Percutaneous closure of patent foramen ovale and atrial septal defect, Pulmonary artery hypertension, Structural heart disease, Transcatheter therapies, Valvular heart disease

Hospital Privileges

M Health Fairview University of Minnesota Medical Center